286 related articles for article (PubMed ID: 21821523)
21. Coronary no-reflow phenomenon: from the experimental laboratory to the cardiac catheterization laboratory.
Rezkalla SH; Kloner RA
Catheter Cardiovasc Interv; 2008 Dec; 72(7):950-7. PubMed ID: 19021281
[TBL] [Abstract][Full Text] [Related]
22. [Beneficial effects of adenosine on myocardial no-reflow in a mini-swine model of acute myocardial infarction and reperfusion].
Zhao JL; Yang YJ; Jing ZC; Wu YJ; You SJ; Yang WX; Meng L; Tian Y; Chen JL; Gao RL; Chen ZJ
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 May; 33(5):453-8. PubMed ID: 15932708
[TBL] [Abstract][Full Text] [Related]
23. [Myocardial no-reflow phenomenon: recent knowledges].
Pontecorvo ML; Spaziani C; Montone RA; Cosentino N; Minelli S; Niccoli G
Recenti Prog Med; 2011 Feb; 102(2):53-7. PubMed ID: 21513120
[TBL] [Abstract][Full Text] [Related]
24. Randomized evaluation of intracoronary nitroprusside vs. adenosine after thrombus aspiration during primary percutaneous coronary intervention for the prevention of no-reflow in acute myocardial infarction: the REOPEN-AMI study protocol.
Niccoli G; D'amario D; Spaziani C; Cosentino N; Marino M; Rigattieri S; Schiavo PL; De Vita MR; Tarantino F; Bartorelli A; Fabbiocchi F; Prati F; Imola F; Valgimigli M; Ferrari R; Crea F
J Cardiovasc Med (Hagerstown); 2009 Jul; 10(7):585-92. PubMed ID: 19384242
[TBL] [Abstract][Full Text] [Related]
25. Management of No-Reflow Phenomenon in the Catheterization Laboratory.
Rezkalla SH; Stankowski RV; Hanna J; Kloner RA
JACC Cardiovasc Interv; 2017 Feb; 10(3):215-223. PubMed ID: 28183461
[TBL] [Abstract][Full Text] [Related]
26. [Significance of coronary perfusion for therapeutic success in myocardial infarct].
Spiecker M; Erbel R; Janssen H; Meyer J
Herz; 1994 Dec; 19(6):353-9. PubMed ID: 7843691
[TBL] [Abstract][Full Text] [Related]
27. Cardiac endothelin release and infarct size, myocardial blood flow, and ventricular function in canine infarction and reperfusion.
Kelly RF; Hursey TL; Schaer GL; Piotrowski MJ; Dee SV; Parrillo JE; Hollenberg SM
J Investig Med; 1996 Dec; 44(9):575-82. PubMed ID: 9035612
[TBL] [Abstract][Full Text] [Related]
28. Pathophysiology of the no-reflow phenomenon.
Vrints CJ
Acute Card Care; 2009; 11(2):69-76. PubMed ID: 19526383
[TBL] [Abstract][Full Text] [Related]
29. Progressive failure of coronary flow during reperfusion of myocardial infarction: documentation of the no reflow phenomenon with positron emission tomography.
Jeremy RW; Links JM; Becker LC
J Am Coll Cardiol; 1990 Sep; 16(3):695-704. PubMed ID: 2387943
[TBL] [Abstract][Full Text] [Related]
30. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV;
Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033
[TBL] [Abstract][Full Text] [Related]
31. Percutaneous coronary intervention and the no-reflow phenomenon.
van Gaal WJ; Banning AP
Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):715-31. PubMed ID: 17605650
[TBL] [Abstract][Full Text] [Related]
32. Further insights into the no-reflow phenomenon after primary angioplasty in acute myocardial infarction: the role of microthromboemboli.
Sakuma T; Leong-Poi H; Fisher NG; Goodman NC; Kaul S
J Am Soc Echocardiogr; 2003 Jan; 16(1):15-21. PubMed ID: 12514630
[TBL] [Abstract][Full Text] [Related]
33. Myocardial no-reflow in humans.
Niccoli G; Burzotta F; Galiuto L; Crea F
J Am Coll Cardiol; 2009 Jul; 54(4):281-92. PubMed ID: 19608025
[TBL] [Abstract][Full Text] [Related]
34. Effects of L-NAME on coronary blood flow, infarct size and the extent of the no-reflow phenomenon.
Pierrakos CN; Tsolakis EJ; Pozios IA; Diakos N; Charitos E; Malliaras K; Bonios MJ; Lazaris N; Papazoglou P; Venetsanakos J; Papalois A; Terrovitis JV; Nanas JN
Int J Cardiol; 2013 Sep; 167(6):3000-5. PubMed ID: 23022088
[TBL] [Abstract][Full Text] [Related]
35. Intracoronary injection of drugs to treat no--reflow phenomenon and microcirculatory dysfunction.
Rognoni A; Lupi A; Cavallino C; Secco GG; Rosso R; Bongo AS
Cardiovasc Hematol Agents Med Chem; 2013 Jun; 11(2):84-8. PubMed ID: 22973862
[TBL] [Abstract][Full Text] [Related]
36. [The no-reflow phenomenon following percutaneous coronary intervention].
Schwartzenberg S; Halkin A; Finkelstein A; Keren G; Banai S
Harefuah; 2009 Jun; 148(6):381-5, 411. PubMed ID: 19902604
[TBL] [Abstract][Full Text] [Related]
37. Myocardial 'no-reflow'--diagnosis, pathophysiology and treatment.
Wong DT; Puri R; Richardson JD; Worthley MI; Worthley SG
Int J Cardiol; 2013 Sep; 167(5):1798-806. PubMed ID: 23357047
[TBL] [Abstract][Full Text] [Related]
38. Serial measurement of hFABP and high-sensitivity troponin I post-PCI in STEMI: how fast and accurate can myocardial infarct size and no-reflow be predicted?
Uitterdijk A; Sneep S; van Duin RW; Krabbendam-Peters I; Gorsse-Bakker C; Duncker DJ; van der Giessen WJ; van Beusekom HM
Am J Physiol Heart Circ Physiol; 2013 Oct; 305(7):H1104-10. PubMed ID: 23873799
[TBL] [Abstract][Full Text] [Related]
39. Mechanical assistance by intra-aortic balloon pump counterpulsation during reperfusion increases coronary blood flow and mitigates the no-reflow phenomenon: an experimental study.
Pierrakos CN; Bonios MJ; Drakos SG; Charitos EI; Tsolakis EJ; Ntalianis A; Nanas SN; Charitos CE; Nanas JN; Terrovitis JV
Artif Organs; 2011 Sep; 35(9):867-74. PubMed ID: 21726241
[TBL] [Abstract][Full Text] [Related]
40. The coronary circulation in acute myocardial ischaemia/reperfusion injury: a target for cardioprotection.
Hausenloy DJ; Chilian W; Crea F; Davidson SM; Ferdinandy P; Garcia-Dorado D; van Royen N; Schulz R; Heusch G
Cardiovasc Res; 2019 Jun; 115(7):1143-1155. PubMed ID: 30428011
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
